Patents Assigned to GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO., LTD.
  • ISOQUINOLINONE DERIVATIVES SERVING AS ROCK PROTEIN KINASE INHIBITORS AND USE THEREOF
    Publication number: 20230024516
    Abstract: Disclosed are a series of isoquinolone derivatives as ROCK protein kinase inhibitors and uses thereof in preparing medicaments for ROCK protein kinase inhibitor-related glaucoma or ocular hypertension diseases. Specially, disclosed are a compound of formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 22, 2020
    Publication date: January 26, 2023
    Applicant: GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO., LTD.
    Inventors: Yizhi Liu, Yandong Wang, Lingyun Wu, Xu You, Zheming Xiao, Shuhui Chen
  • Crystal form of lanosterol prodrug compound and application thereof
    Patent number: 11149055
    Abstract: The present invention relates to a crystal form of a compound of formula (I) and an application thereof in preparing a drug for treating an ophthalmic disease.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: October 19, 2021
    Assignee: GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO., LTD.
    Inventors: Yizhi Liu, Yandong Wang, Xiaolin Li, Zhi Luo, Haiying He, Jian Li, Shuhui Chen
  • CRYSTAL FORM OF LANOSTEROL PRODRUG COMPOUND AND APPLICATION THEREOF
    Publication number: 20210246158
    Abstract: The present invention relates to a crystal form of a compound of formula (I) and an application thereof in preparing a drug for treating an ophthalmic disease.
    Type: Application
    Filed: July 25, 2019
    Publication date: August 12, 2021
    Applicant: GUANGZHOU OCUSUN OPHTHALMIC BIOTECHNOLOGY CO., LTD.
    Inventors: Yizhi LIU, Yandong WANG, Xiaolin LI, Zhi LUO, Haiying HE, Jian LI, Shuhui CHEN